
Shantell Laketa Heiber
Examiner (ID: 4200, Phone: (571)272-0886 , Office: P/2641 )
| Most Active Art Unit | 2645 |
| Art Unit(s) | 2641, 2644, 2645, 2617 |
| Total Applications | 943 |
| Issued Applications | 655 |
| Pending Applications | 110 |
| Abandoned Applications | 212 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7060594
[patent_doc_number] => 20050002954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Peptide-based vaccine for influenza'
[patent_app_type] => utility
[patent_app_number] => 10/846548
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7331
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10846548
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/846548 | Peptide-based vaccine for influenza | May 16, 2004 | Issued |
Array
(
[id] => 4820570
[patent_doc_number] => 20080226677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Recombinant virus vector for gene transfer into lymphoid cells'
[patent_app_type] => utility
[patent_app_number] => 10/843877
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 55335
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10843877
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/843877 | Recombinant virus vector for gene transfer into lymphoid cells | May 11, 2004 | Abandoned |
Array
(
[id] => 7424837
[patent_doc_number] => 20040208899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Kits for producing and using immunogenic compositions that include SIRS virus'
[patent_app_type] => new
[patent_app_number] => 10/839877
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12956
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10839877
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/839877 | Immunogenic compositions that include SIRS virus | May 5, 2004 | Issued |
Array
(
[id] => 7457314
[patent_doc_number] => 20040197351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine'
[patent_app_type] => new
[patent_app_number] => 10/832353
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6829
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197351.pdf
[firstpage_image] =>[orig_patent_app_number] => 10832353
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/832353 | Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine | Apr 26, 2004 | Issued |
Array
(
[id] => 5154268
[patent_doc_number] => 20070037151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Cd4+ human papillomavirus (hpv) epitopes'
[patent_app_type] => utility
[patent_app_number] => 10/546497
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15627
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546497
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546497 | Cd4+ human papillomavirus (hpv) epitopes | Apr 22, 2004 | Abandoned |
Array
(
[id] => 7202308
[patent_doc_number] => 20050042599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Immunological methodology for discerning human papillomavirus contemplating peptides from the E7 early coding region of HPV 16'
[patent_app_type] => utility
[patent_app_number] => 10/827007
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4982
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042599.pdf
[firstpage_image] =>[orig_patent_app_number] => 10827007
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/827007 | Immunological methodology for discerning human papillomavirus contemplating peptides from the E7 early coding region of HPV 16 | Apr 18, 2004 | Abandoned |
Array
(
[id] => 7202309
[patent_doc_number] => 20050042600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Immunological methodology for discerning human papillomavirus contemplating peptides from the E7 early coding region of HPV 16'
[patent_app_type] => utility
[patent_app_number] => 10/827083
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4982
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042600.pdf
[firstpage_image] =>[orig_patent_app_number] => 10827083
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/827083 | Immunological methodology for discerning human papillomavirus contemplating peptides from the E7 early coding region of HPV 16 | Apr 18, 2004 | Abandoned |
Array
(
[id] => 541540
[patent_doc_number] => 07163685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-16
[patent_title] => 'Human cytomegalovirus antigens expressed in MVA and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/825629
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 50
[patent_no_of_words] => 25684
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/163/07163685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10825629
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/825629 | Human cytomegalovirus antigens expressed in MVA and methods of use | Apr 15, 2004 | Issued |
Array
(
[id] => 4511873
[patent_doc_number] => 07910111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'Inhibitors of N-ethylmaleimide sensitive factor'
[patent_app_type] => utility
[patent_app_number] => 10/553686
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17282
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910111.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553686
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553686 | Inhibitors of N-ethylmaleimide sensitive factor | Apr 14, 2004 | Issued |
Array
(
[id] => 7341587
[patent_doc_number] => 20040191273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Methods and compositions for obtaining disease protection for economically important animals'
[patent_app_type] => new
[patent_app_number] => 10/823150
[patent_app_country] => US
[patent_app_date] => 2004-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17626
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20040191273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10823150
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/823150 | Methods and compositions for obtaining disease protection for economically important animals | Apr 12, 2004 | Abandoned |
Array
(
[id] => 5034148
[patent_doc_number] => 20070098687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Pharmaceutical composition containing interferon for the treatment of hpv infections'
[patent_app_type] => utility
[patent_app_number] => 10/553387
[patent_app_country] => US
[patent_app_date] => 2004-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1236
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098687.pdf
[firstpage_image] =>[orig_patent_app_number] => 10553387
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/553387 | Pharmaceutical composition containing interferon for the treatment of hpv infections | Apr 5, 2004 | Abandoned |
Array
(
[id] => 7149324
[patent_doc_number] => 20040170965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Mixed cell diagnostic systems'
[patent_app_type] => new
[patent_app_number] => 10/813852
[patent_app_country] => US
[patent_app_date] => 2004-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24960
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20040170965.pdf
[firstpage_image] =>[orig_patent_app_number] => 10813852
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/813852 | Mixed cell diagnostic systems | Mar 29, 2004 | Issued |
Array
(
[id] => 5672463
[patent_doc_number] => 20060177817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Codon-optimized papilloma virus sequences'
[patent_app_type] => utility
[patent_app_number] => 10/551057
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8628
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551057
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551057 | Optimized expression of HPV31 L1 in yeast | Mar 18, 2004 | Issued |
Array
(
[id] => 7677752
[patent_doc_number] => 20040152074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Seroreactive regions on HPV 16 proteins E1 and E2'
[patent_app_type] => new
[patent_app_number] => 10/801820
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4898
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152074.pdf
[firstpage_image] =>[orig_patent_app_number] => 10801820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/801820 | Seroreactive regions on HPV 16 proteins E1 and E2 | Mar 16, 2004 | Abandoned |
Array
(
[id] => 7677643
[patent_doc_number] => 20040152183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Purification of adenovirus and AAV'
[patent_app_type] => new
[patent_app_number] => 10/470604
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12479
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152183.pdf
[firstpage_image] =>[orig_patent_app_number] => 10470604
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/470604 | Purification of adenovirus and AAV | Mar 1, 2004 | Issued |
Array
(
[id] => 7255817
[patent_doc_number] => 20040259773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Peptides for inhibition of herpes simplex virus entry'
[patent_app_type] => new
[patent_app_number] => 10/790435
[patent_app_country] => US
[patent_app_date] => 2004-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13746
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259773.pdf
[firstpage_image] =>[orig_patent_app_number] => 10790435
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/790435 | Peptides for inhibition of herpes simplex virus entry | Feb 29, 2004 | Abandoned |
Array
(
[id] => 7168425
[patent_doc_number] => 20050202026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Method for producing immunoglobulins containing protection proteins and their use'
[patent_app_type] => utility
[patent_app_number] => 10/781989
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27494
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202026.pdf
[firstpage_image] =>[orig_patent_app_number] => 10781989
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/781989 | Method for producing immunoglobulins containing protection proteins and their use | Feb 17, 2004 | Issued |
Array
(
[id] => 341503
[patent_doc_number] => 07501261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-10
[patent_title] => 'Detection of HPV-induced invasive cancers and their precursor lesions with invasive potential'
[patent_app_type] => utility
[patent_app_number] => 10/551584
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 1
[patent_no_of_words] => 9655
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/501/07501261.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551584 | Detection of HPV-induced invasive cancers and their precursor lesions with invasive potential | Feb 16, 2004 | Issued |
Array
(
[id] => 879349
[patent_doc_number] => 07354714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-08
[patent_title] => 'Production and applications for polyvalent vaccines against diseases caused by papilloma viruses'
[patent_app_type] => utility
[patent_app_number] => 10/778936
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 6913
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/354/07354714.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778936
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778936 | Production and applications for polyvalent vaccines against diseases caused by papilloma viruses | Feb 12, 2004 | Issued |
Array
(
[id] => 7275502
[patent_doc_number] => 20040234953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Japanese macaque herpesvirus nucleic acid and polypeptide sequences and their use'
[patent_app_type] => new
[patent_app_number] => 10/779597
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26620
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234953.pdf
[firstpage_image] =>[orig_patent_app_number] => 10779597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/779597 | Japanese macaque herpesvirus nucleic acid and polypeptide sequences and their use | Feb 11, 2004 | Abandoned |